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Abstract
Background: Splicing of DNA molecules is an important task in molecular biology that facilitates
cloning, mutagenesis and creation of chimeric genes. Mutagenesis and DNA splicing techniques
exist, some requiring restriction enzymes, and others utilize staggered reannealing approaches.
Results: A method for DNA splicing and mutagenesis without restriction enzymes is described.
The method is based on mild template-dependent polymerization arrest with two molecules of
cytosine arabinose (Ara-C) incorporated into PCR primers. Two rounds of PCR are employed: the
first PCR produces 5' overhangs that are utilized for DNA splicing. The second PCR is based on
polymerization running through the Ara-C molecules to produce the desired final product. To
illustrate application of the run through stop mutagenesis and DNA splicing technique, we have
carried out splicing of two segments of the human cofilin 1 gene and introduced a mutational
deletion into the product.
Conclusion: We have demonstrated the utility of a new PCR-based method for carrying out DNA
splicing and mutagenesis by incorporating Ara-C into the PCR primers.
Background
Splicing of DNA molecules is an important task in molec-
ular biology that facilitates cloning, mutagenesis and the
creation of chimeric genes. While the advent of restriction
enzymes substantially advanced DNA splicing techniques,
they cannot be applied universally, and their use is limited
to enzyme-specific loci. Other techniques like site-
directed mutagenesis by overlap extension [SOE; [1]],
insertional mutagenesis with the megaprimer technique
[2] and staggered reannealing [3,4] have further improved
DNA mutagenesis and splicing. Each method offers
advantages and inherent drawbacks. Another cloning
approach involving the formation of 5' overhangs utilizes
incorporation of nucleotide derivatives into PCR primers
[5-7] that stall polymerization. These techniques are
dependent on an established set of optimal conditions for
strong polymerization arrest, including the correct choice
of polymerase or the incorporation of three ribonucle-
otide derivatives in the primer [7]. Furthermore, chimeric
DNA/RNA primers need to be removed and reverse-tran-
scribed in order for the splicing to be completed.
Although in the past we have successfully used the SOE
technique for mutagenesis and splicing, we encountered
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difficulties while constructing larger genes. That led us to
develop the staggered reannealing method [3,4]. This
method proved to be useful as well, however, its efficiency
declined as the gene to be mutagenized exceeded 1000 bp.
Although these techniques allow splicing of any two DNA
fragments without the need for restriction enzymes, their
efficiency is inversely related to the length of the DNA
fragments involved, since these techniques rely on the
successful melting and reannealing of DNA to create
matching overhangs. We sought to offer an alternative
approach to facilitate the splicing of any two DNA seg-
ments for mutagenesis and construction of chimeric
genes. Our technique utilizes two rounds of PCR, and is
based on moderate template-dependent polymerization
arrest using cytosine arabinose (Ara-C).
Ara-C is a nucleotide derivative (Fig 1) that is widely used
in cancer therapeutics [8]. It is a competitive inhibitor of
DNA polymerase and also affects polymerization initia-
tion [9,10]. Ara-C exerts it therapeutic action on cellular
DNA polymerase after phosphorylation by an endog-
enous kinase. Once phosphorylated, Ara-C facilitates
inhibition of DNA replication in cancer cells. Sanger et al,
in their search for polymerization terminating agents for
use in sequencing techniques, found that while dideoxy-
nucleotides were strong polymerase terminators, Ara-C
only weakly halted polymerization [11]. Therefore, even
today, dideoxynucleotides remain the terminators of
choice in sequencing reactions. Previous studies have
shown that while Ara-C could serve as a substrate for
mammalian polymerases, it terminates polymerization by
some prokaryotic polymerases [11].
Here we used Ara-C both as DNA polymerase inhibitor
and template for DNA mutagenesis and splicing.
Results and discussion
We were searching for a mild template-dependent polym-
erization terminator. The rationale for mild termination is
as follows: Termination must be strong enough to create
5' overhangs in the first PCR reaction, but weak enough to
allow the polymerase to continue through the modified
nucleotide during the second round of PCR (Fig 2). For
the reasons mentioned above, Ara-C was chosen for use in
the present study.
As proof of principal, a 20 bp deletion in the human cofi-
lin 1 gene was created. We tried to splice together two seg-
ments of the gene: one 5' (237 bp) and one 3' (309 bp)
segment (Fig 2). Primers were designed with one or two
Ara-C molecules replacing native deoxycytidine nucle-
otides. When two Ara-C molecules were incorporated into
the primer (Hospital for Sick Children, Toronto, Canada),
template-dependent termination can potentially occur
before, after one, or after two Ara-C molecules. Therefore,
to determine the termination location, we designed one
side of the overhang to accommodate termination after
two Ara-C molecules, and the other side of the overhang
to accommodate termination after one Ara-C molecule
(Fig 3).
There were a total of 8 PCR reactions that included two
Ara-C primers for each of the two segments, and the two
polymerases (Taq and Pfu) for each set of primers. PCR
products were gel-isolated. At this stage, gel-isolation is
essential in order to remove any of the original plasmid
that might serve as a template in the second PCR reaction.
Alternatively, the original plasmid may be eliminated by
digestion with DpnI, although this option is less recom-
mended, since traces of undigested plasmid could affect
the outcome of the second PCR reaction. Corresponding
segments to be spliced were combined (total of four
tubes) and ligated. As indicated above, the rationale for
this technique is that Ara-C is a mild polymerization ter-
minator, and therefore it will produce a mixture of cohe-
sive and blunt ends. Hence, the reaction is expected to
both terminate (producing sticky ends essential for the
splicing phase) and run through the Ara-C (producing
blunt ends; this feature is essential to the second PCR reac-
tion). Therefore, lowered concentration of ligase and
reduced ligation time were used to optimize conditions to
favor cohesive end ligation. The products of the ligase
reaction were amplified by the second PCR with Taq or
Pfu polymerases using the sense primer A, and the anti-
sense primer B, which span the cofilin 1 gene. This PCR
reaction produced the expected 552 bp product (blunt
end ligation, is expected to produce an extra duplicated
piece of DNA of 15 bp). The PCR products were either
sequenced directly, or cloned into a plasmid and then
sequenced. Based on sequencing results, we observed that
incorporation of two Ara-C nucleotides into the PCR
primers yielded the expected product. This suggests that
the two molecules of Ara-C provided the desired mild ter-
mination to produce a product with 5' overhangs, but also
allowed the polymerase to run through during the 2nd
PCR. Furthermore, based on the design of the primers, the
polymerization stalled both after the first and the second
Ara-C molecule. Both 5 and 30 min incubations with
DNA Ligase were sufficient to preferentially ligate the
cohesive ends. This further suggests that two adjacent
molecules of Ara-C produce 5' overhangs. Even though
both 5 and 30 min ligations were successful in producing
the desired product, it is not recommended to allow the
reaction to proceed for a prolonged time, nor is it recom-
mended to use high levels of ligase, since these conditions
may facilitate blunt end ligation that may produce a mix-
ture of the blunt and cohesive end products. Both Pfu and
Taq polymerases were equally capable of producing termi-
nation products in the first PCR, while still running
through the Ara-C in the second PCR. When one moleculeBMC Biotechnology 2005, 5:23 http://www.biomedcentral.com/1472-6750/5/23
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Structure of cytidine and its derivatives Figure 1
Structure of cytidine and its derivatives. The derivatives featured in this figure vary in their sugar substitutes. Note that in 
Cytosine Arabinose (Ara-C), the arabinose sugar contains hydroxyl groups in positions 3 and 5 in a similar orientation to 
native ribose, thus permitting reaction with other nucleotides in DNA synthesis. However, the hydroxyls in positions 2 and 3 
are in the trans orientation. Comparing position 2 on the arabinose ring to that of 2-deoxyribose reveals that the hydrogen in 
2-deoxyribose, that is in trans configuration to hydroxyl 3, is replaced by the hydroxyl group found on arabinose. It should be 
emphasized that there are two types of polymerization arrest: a. Chain termination- the nucleotide is incorporated into the 
nascent DNA strand and synthesis is stalled because no new nucleotide is added. Dideoxy derivatives stall elongation after 
incorporation into the nascent DNA strand because they do not have hydroxl in position 3. Arabinose nucleotides also belong 
to this group, but they offer only partial stalling [11]. b. Template-dependent termination-nucleotides already incorporated in 
the DNA (e.g. in primers) are able to stall polymerization when the polymerase reads the template. It is believed that due to 
stereo restraints, the polymerase falls off the template. The frequency of this event determines the efficiency of the stalling. 
Arabinose derivatives belong to this group. The property of template-dependent termination of Ara-C was utilized in this study 
to create 5' overhangs in the first PCR. However, since the template-dependent termination by Ara-C is moderate, it was uti-
lized for the amplification in the second PCR.
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Schematic representation of run through stop DNA mutagenesis and splicing technique with Ara-C Figure 2
Schematic representation of run through stop DNA mutagenesis and splicing technique with Ara-C. In this 
example two pieces of DNA are to be spliced (5' and 3' DNA segments) and mutated with an insertion of additional DNA. The 
5' segment is amplified using PCR primers A (sense) and Ara-C2-A (anti-sense). Primer Ara-C2-A is designed to contain hybrid 
DNA with two adjacent molecules of Ara-C to stall polymerisation and produce a 5' overhang. Mutational addition is also 
incorporated into this primer. (Note that in this paper we created a mutational deletion in the human cofilin 1 gene, but here 
for illustration purpose, we describe a mutational addition). The 3' segment is amplified using PCR primers Ara-C2-B (sense) 
and B (anti-sense). Primer Ara-C2-B contains overlapping sequence with primer Ara-C2-A, and 2 molecules of Ara-C are 
incorporated to stall polymerization and produce a 5' overhang that is complementary to the overhang in Ara-C2-A. Both Ara-
C primers are phosphorylated for down stream ligation. Since two adjacent Ara-C molecules produce moderate termination, 
PCR products contain a mixture of 5' overhang and blunt end DNA. Each PCR product is gel-isolated and subjected to short 
ligation, where cohesive end ligation is predominant. A portion of the ligation reaction is then subjected to a second PCR reac-
tion, using primers A and B that span the entire mutated chimeric DNA. As mentioned above, 2 Ara-C molecules are moder-
ate polymerization terminators. This assures that at the first round of the second PCR, the polymerase will run through the 
Ara-C in the template and incorporate native dGMP, that will ensure in turn proper polymerization in the next rounds and a 
product that will contain the native dCMP. For cloning purposes of the final PCR product, primers A abd B can include restric-
tion sites (as used in this study). Alternatively, by using Taq polymerase in the second PCR reaction, the product can be cloned 
into TA cloning plasmids. Another alternative is to design primers A and B to contain at least 2 molecules of Ara-C to produce 
5' overhangs to match cloning plasmids.
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of Ara-C was incorporated in the PCR primers, no termi-
nation could be observed, as seen by the addition of a 15
bp segment in the PCR product indicative of blunt end
ligation. Even ligation for 5 min in reduced concentration
of ligase failed to produce cohesive end ligation when
only one Ara-C was employed.
The run through stop method utilizes a novel approach
for DNA splicing and mutagenesis. While other mutagen-
esis techniques like SOE, megaprimer and staggered rean-
nealing create matching overhangs after melting and
reannealing, the run through stop method creates match-
ing overhangs by polymerization arrest with Ara-C. We
were motivated to design the Ara-C approach because we
were not successful in creating gene mutations with the
other techniques. Hence, the run through stop offers a
good alternative to these techniques.
It has been previously demonstrated that utilizing abasic
or RNA nucleotides like tetrahydrofuran derivative or 2-o-
methyl ribonucleotide in PCR primers produced 5' over-
hangs that facilitated cloning of DNA fragments into plas-
mids [5-7]. These approaches were dependent on strong
polymerization termination by the nucleotides. Our tech-
nique established the conditions for mild termination of
DNA polymerization with two Ara-C molecules. This ena-
bles us to use the Ara-C-containing primers in two steps of
PCR for DNA splicing and mutagenesis. Although in the
present study we used relatively short segments of DNA
for proof of principal (~500 bp of the human cofilin
gene), this technique, unlike the staggered reannealing
technique, is not limited to short DNA fragments. Since
both rounds of PCR in the present study are based on con-
ventional PCR, the length limit of the DNA fragments to
be mutagenized is that of the PCR technique.
Conclusion
The run through stop method can be summarized in four
steps:
1. Amplify two segments of DNA to be spliced using PCR,
with phosphorylated primers containing two adjacent
molecules of Arabinose nucleotide with overlapping
sequence.
2. Gel-isolate the two DNA products, combine and ligate.
3. Amplify the spliced product with flanking primers
using PCR.
4. Clone the product into a plasmid.
Methods
First PCR
For the first PCR, 4 primers were designed: Primers A and
B flanking the human cofilin 1 gene (Fig 2) and two prim-
ers containing Ara-C molecules (Figs 2 and 3)). Primer A-
5'-ATActgcagATGGCCGCTGGTGTGGCTGTCTGTG-3'-
sense primer of human cofilin 1. Lower case letters repre-
sent Pst I sequence and bold letters represent Ala to Ser
mutagenesis for down stream usage. Primer Ara-C2-A-5'-
GGCATAGCGGCAGTCXXAAAGGTGGCGTAGGGATCG-
3'-anti-sense primer that contains two Ara-C molecules
(XX) and designed to delete a 20 bp segment from the
human cofilin 1 gene (Fig 3). Primer Ara-C2-B-5'-
ACTGCCCGTTATGCXXTCTATGATGCAACCTATGAG-3'-
Ara-C primer assignment Figure 3
Ara-C primer assignment. Shown is the double-stranded DNA segment of human cofilin 1 gene that was used for mutagen-
esis. Capital letters and arrows represent primers containing Ara-C molecules. Lower case letters represent deleted nucle-
otides, achieved with primer Ara-C2-A (broken line). Xs in primers denote Ara-C molecules that replace the original deoxy 
cytidine molecules. Note that the 5' end of primer Ara-C2-A was designed to produce an overhang, that restricts ligation to 
the 3' segment of the PCR product (see also Fig 2) only if termination occurred after the first Ara-C molecule. The 5' segment 
of primer Ara-C2-B was designed to produce an overhang that restricts ligation to the 5' segment of the PCR product (see Fig 
2) only if termination occurred after two Ara-C molecules. Additionally, two primers containing only one Ara-C molecule 
insertion were synthesized (not shown).Publish with BioMed Central    and   every 
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sense primer that contains two Ara-C molecules (Fig 3).
Additionally, two primers containing only one Ara-C mol-
ecule insertion were synthesized. Primer B-5'-CAActcgag-
GGCTGCCAGATGCTCCAGGCAGG-3'-anti-sense primer
of the 3' end of human cofilin 1 gene. Lower case letters
represent the sequence for the Xho I gene. In the first PCR,
Primer A was used with primer Ara-C2-A, and Primer Ara-
C2-B was used with primer B. In the second PCR, primer
A was used with primer B (see also Fig 2).
Ara-C primers were phosphorylated for 30 min at room
temperature using T4 polynucleotide kinase (Invitrogen,
Burlington, ON), followed by inactivation at 65°C for 10
min, and used for PCR with no further purification. PCR
was performed with corresponding primers (see above
and Fig 2, 3) using 1 U Pfu polymerase (Stratagene, La
Jolla, CA) or 1 U of Taq polymerase (Sigma, Oakville,
ON), and plasmid pOTB7 containing the human cofilin 1
gene as template (ATCC, Manassas, VA). PCR conditions
were as follows: heating to 94°C for 5 min; 40 cycles of:
94°C, 55°C and 72°C each for 30 seconds; final elonga-
tion for 7 min. PCR products were gel-isolated using Min-
Elute Plasmid Purification Kits (Qiagen, Mississauga,
ON). Corresponding segments to be spliced were com-
bined (total of four tubes) and ligated for 30 min with 400
U, or five min with 200 U of T4 ligase (NEB, Pickering,
ON) followed by inactivation for 10 min at 65°C.
Second PCR
Two µl of the ligase reaction were amplified by the second
PCR with Taq or Pfu polymerase using the sense primer A,
and the anti-sense primer B. Conditions for the second
PCR were similar to those of the first PCR. The PCR prod-
ucts were purified (Qiagen). Alternatively, the PCR prod-
ucts were subjected to double digestion with PstI and
XhoI followed by ligation into plasmid pcDNA3.1Zeo+
(Invitrogen). One µl of ligation reaction was used to trans-
form 20 µl competent cells (DH5α; Invitrogen), using a
short procedure: competent cells were incubated for 5
min on ice, and heat-shocked by immediate plating on
pre-warmed (37°C) agar plates. Plasmids were prepared
using Fast Plasmid Mini Kit (Eppendorf, Mississauga,
ON), and sequenced using the T7 primer.
DNA sequencing
The products of PCR, as well as the products that were
cloned into plasmid pcDNA3.1Zeo+ were sequenced in
both directions, utilizing primers A and B, or primer T7,
respectively (Hospital for Sick Children).
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